Holen Sie sich die Stockscreener-App
9.78
1.61%
-0.16
Schlusskurs vom Vortag:
$9.94
Offen:
$9.93
24-Stunden-Volumen:
136.80K
Relative Volume:
0.11
Marktkapitalisierung:
$655.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-103.21M
KGV:
-2.126
EPS:
-4.6001
Netto-Cashflow:
$-26.70M
1W Leistung:
+2.41%
1M Leistung:
+16.71%
6M Leistung:
+170.17%
1J Leistung:
+56.48%
1-Tages-Spanne:
$9.64
$10.00
1-Wochen-Bereich:
$9.24
$10.20
52-Wochen-Spanne:
$2.65
$12.25
Engene Holdings Inc Stock (ENGN) Company Profile
Firmenname
Engene Holdings Inc
Sektor
Branche
Telefon
(514) 332-4888
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
9.78 | 665.83M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | Jefferies | Buy |
| 2025-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-14 | Herabstufung | UBS | Buy → Neutral |
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-27 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-03-28 | Eingeleitet | UBS | Buy |
| 2024-03-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
What is enGene Holdings Inc. Equity Warrant’s valuation compared to sector2025 Market Overview & Verified Technical Trade Signals - mfd.ru
Does enGene Holdings Inc. Equity Warrant meet Warren Buffett’s criteria2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - mfd.ru
10 Best Low Volatility Canadian Stocks to Buy - Insider Monkey
Can enGene Holdings Inc Equity Warrant lead its sector in growthJuly 2025 Catalysts & Consistent Profit Trade Alerts - baoquankhu1.vn
Can enGene Holdings Inc. Equity Warrant grow without external fundingJuly 2025 Weekly Recap & Verified Trade Idea Suggestions - mfd.ru
enGene CEO Talks Detalimogene for Community Urology as LEGEND Study Hits Full Enrollment - MarketBeat
Merger Talk: Should I hold or sell enGene Holdings Inc. Equity Warrant stock in 2025July 2025 Drop Watch & Low Risk Profit Maximizing Plans - mfd.ru
Will enGene Holdings Inc. stock hit new highs in YEARJuly 2025 Price Swings & Daily Growth Stock Investment Tips - mfd.ru
How does enGene Holdings Inc compare to its peersWeekly Trade Report & Weekly High Return Stock Forecasts - baoquankhu1.vn
Retail Trends: Will enGene Holdings Inc stock hit new highs in YEARJuly 2025 Earnings & Fast Moving Trade Plans - baoquankhu1.vn
Levels Update: Will enGene Holdings Inc stock benefit from M AJuly 2025 Rallies & Expert Approved Trade Ideas - baoquankhu1.vn
enGene CEO to Highlight Genetic Medicine Strategy at Guggenheim Biotech Summit 2026 - The Globe and Mail
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - BioSpace
enGene to Spotlight Bladder Cancer Gene Therapy at Guggenheim Biotech Summit 2026 - TipRanks
Pharma News: How does enGene Holdings Inc compare to its peersTrade Ideas & Long-Term Capital Growth Ideas - baoquankhu1.vn
enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Growth Report: Can enGene Holdings Inc benefit from deglobalizationJuly 2025 Trends & Weekly High Return Stock Forecasts - baoquankhu1.vn
Insider Sell: Can SAIHEAT Limited Equity Warrant be recession proofPortfolio Gains Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Is enGene Holdings Inc a stock for growth or value investors2025 Market Outlook & AI Driven Stock Reports - baoquankhu1.vn
EnGene Holdings Inc (ENGN) surging after positive phase 2 LEGEND trial - MSN
enGene (NASDAQ:ENGN) Shares Up 8.1%What's Next? - MarketBeat
Portfolio Shifts: Is enGene Holdings Inc a stock for growth or value investorsQuarterly Market Summary & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Both private equity firms who control a good portion of enGene Holdings Inc. (NASDAQ:ENGN) along with institutions must be dismayed after last week's 16% decrease - Yahoo Finance
Retail Trends: Is enGene Holdings Inc Equity Warrant stock a value trap2025 Big Picture & Low Drawdown Trading Techniques - baoquankhu1.vn
Macro Review: Is The Gabelli Healthcare Wellness Trust exposed to political riskWeekly Trade Review & Advanced Technical Analysis Signals - baoquankhu1.vn
Targets Report: Is VTMX a top pick in the sectorMarket Performance Report & Low Risk Entry Point Guides - baoquankhu1.vn
Jefferies initiates coverage on Engene stock with Buy rating By Investing.com - Investing.com South Africa
enGene (NASDAQ:ENGN) Shares Gap UpHere's What Happened - MarketBeat
Jefferies Financial Group Initiates Coverage on enGene (NASDAQ:ENGN) - MarketBeat
Jefferies Initiates Coverage on enGene With Buy Rating, $28 Price Target - marketscreener.com
Jefferies initiates coverage on Engene stock with Buy rating - Investing.com
Is enGene Holdings Inc. Equity Warrant impacted by rising ratesJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru
enGene (NASDAQ:ENGN) Shares Down 5.7%Here's Why - MarketBeat
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN) - Seeking Alpha
enGene Holdings Closes $130 Million Public Offering - MSN
EnGene extends momentum with another 14% surge on Friday - MSN
Trend Recap: Is HBTA a cyclical or defensive stockMarket Growth Review & Real-Time Chart Breakout Alerts - baoquankhu1.vn
enGene (NASDAQ:ENGN) Reaches New 12-Month High – Time to Buy? - Defense World
Short Squeeze: Is enGene Holdings Inc stock a good dividend stockJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
enGene extends momentum with another 14% surge on Friday (ENGN:NASDAQ) - Seeking Alpha
enGene (NASDAQ:ENGN) Hits New 1-Year HighStill a Buy? - MarketBeat
Profit Recap: What analysts say about enGene Holdings Inc Equity Warrant stockPortfolio Risk Summary & Capital Efficiency Focused Strategies - baoquankhu1.vn
enGene (NASDAQ:ENGN) Stock Price Up 11.3%Time to Buy? - MarketBeat
Aug Reactions: Is Heritage Financial Corporation a speculative investmentWeekly Risk Summary & Expert Approved Momentum Ideas - baoquankhu1.vn
enGene (NASDAQ:ENGN) Sees Strong Trading VolumeWhat's Next? - MarketBeat
enGene Holdings (NASDAQ: ENGN) adds $125M debt facility and new warrants - Stock Titan
Breakout Watch: Is enGene Holdings Inc. benefiting from interest rate changesJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - PharmiWeb.com
Weekly Trades: Does enGene Holdings Inc Equity Warrant stock benefit from AI growth2025 Macro Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital - citybiz
Finanzdaten der Engene Holdings Inc-Aktie (ENGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):